Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anusha Thomas"'
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 13, Iss 1 (2024)
The Severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) infection causes a wide range of neurologic and hematologic manifestations. Herein, we report the case of a 69-year-old Indian male with concurrent Guillain-Barre syndrome (GBS) and hem
Externí odkaz:
https://doaj.org/article/aa62f6a927834199b4e1444c45c237df
Autor:
Xuemei Wang, Jessica Harris, John Thompson, Elad Sharon, Yinghong Wang, Aline Charabaty, Marc S Ernstoff, Jennifer McQuade, Michel Obeid, Stephen Hanauer, Amishi Shah, Fangwen Zou, Isabella C Glitza Oliva, David Faleck, Anusha Thomas, Deepika Satish, David M Richards
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/348319be145d4effbb1c77b2ee2b1493
Autor:
Barbara Dutra, Victor Garcia-Rodriguez, Rogelio Garcia, David Szafron, Fiyinfoluwa Abraham, Shruti Khurana, Jonathan Lockhart, Rajan Amin, Yinghong Wang, Anusha Thomas
Publikováno v:
American Journal of Clinical Oncology. 46:94-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f11252cf4d1ddffaeb897b6239dd262
https://doi.org/10.1097/coc.0000000000000981
https://doi.org/10.1097/coc.0000000000000981
Publikováno v:
J Speech Lang Hear Res
Purpose: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects bulbar functions including speech and voice. Voice onset time (VOT) was examined in speakers with ALS in early and late stages to explore the coordination of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380089059adc49b9c34b65f330898c25
https://doi.org/10.1044/2022_jslhr-21-00632
https://doi.org/10.1044/2022_jslhr-21-00632
Autor:
Antonio Pizuorno Machado, Malek Shatila, Isabella C. Glitza Oliva, Mehmet Altan, Bilal Siddiqui, Yan Zhou, Krishnavathana Varatharajalu, Hao Chi Zhang, Anusha Thomas, Yinghong Wang
Publikováno v:
American Journal of Clinical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8cbbbbefadc79276d06c40ea8deef0
https://doi.org/10.1097/coc.0000000000001016
https://doi.org/10.1097/coc.0000000000001016
Autor:
Anusha Thomas, Seung Eun Lee, Malek Shatila, Enrico De Toni, Helga-Paula Török, Najib Ben Khaled, Nicholas Powell, Ryan Weight, David M. Faleck, Yinghong Wang
BACKGROUND AND AIMS: Immune checkpoint inhibitor mediated colitis (IMC) is commonly managed with steroids and biologics. We evaluated the efficacy of ustekinumab (UST) in treating IMC refractory to steroids plus infliximab and/or vedolizumab. RESULTS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edc7a8cb48ec9f4cfa5b62f34983e88
http://hdl.handle.net/10044/1/104402
http://hdl.handle.net/10044/1/104402
Autor:
Alice, Saji, Maneera, Chopra, Jake, Jacob, Mehmet, Altan, Omar, Alhalabi, Amishi Yogesh, Shah, Wei, Qiao, Yinghong, Wang, Anusha, Thomas
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can lead to GI toxicity, termed immune-mediated diarrhea and colitis (IMDC). Standardization of IMDC management and early GI consultation is imperative to control symptoms and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443e7b040e25b08b59fedfe3fcf0ed33
https://doi.org/10.1007/s00432-022-04504-1
https://doi.org/10.1007/s00432-022-04504-1
Autor:
Antonio Pizuorno Machado, Malek Shatila, Cynthia Liu, Jianbo Wang, Mehmet Altan, Hao Chi Zhang, Anusha Thomas, Yinghong Wang
Purpose Immune checkpoint inhibitor (ICI) therapy can predispose patients to immune-related adverse events (irAEs) and autoimmune disease (AD) flare-ups, but the characteristics of irAEs among patients with pre-existing ADs are largely unknown. We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae74a1cd6cd140dbfde8beb03f87788
https://doi.org/10.21203/rs.3.rs-2372243/v1
https://doi.org/10.21203/rs.3.rs-2372243/v1
Autor:
Alice Saji, Maneera Chopra, Jake Jacob, Mehmet Altan, Omar Alhalabi, Amishi Yogesh Shah, Wei Qiao, Yinghong Wang, Anusha Thomas
Purpose Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can lead to GI toxicity, termed immune mediated diarrhea and colitis (IMDC). Standardization of IMDC management and early GI consultation is imperative to control symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf7c03810a3a93753165a2b02a15cf38
https://doi.org/10.21203/rs.3.rs-2216829/v1
https://doi.org/10.21203/rs.3.rs-2216829/v1
Autor:
Antonio Pizuorno Machado, Malek Shatila, Cynthia Liu, Yang Lu, Mehmet Altan, Isabella Glitza Oliva, Dan Zhao, Hao Chi Zhang, Anusha Thomas, Yinghong Wang
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose: Exposure to immune checkpoint inhibitors (ICIs) can predispose to immune-related adverse events (irAEs) involving the gastrointestinal tract. The association between ICIs and bowel perforation has not been well studied. We aimed to describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fd33d3b042ce50674c76e5462a40e5
https://pubmed.ncbi.nlm.nih.gov/36611109
https://pubmed.ncbi.nlm.nih.gov/36611109